CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00659724
NCT00659724N/ACompleted
CompareCT.gov

The Gambro Polyflux HD-C4 Big Ease Of Use And Thrombogenicity Study

Vantive Health LLC·observational·Posted Apr 16, 2008·Updated Jul 24, 2025

In Brief

An observational study for Chronic Kidney Failure. Completed, enrolled 33 participants across 2 sites.

Detailed Summary

The purpose of this study is to collect information on the ease of use and thrombogenicity of the Polyflux HD-C4 Big and Fresenius Optiflux 180NR or 200NR dialyzers under conditions of routine clinical use for hemodialysis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Failure
CountriesUnited States
CollaboratorsAdvanced Dialysis Center of Potomac, Advanced Dialysis Center of Easton, Gambro Renal Products, Inc., Baxter Healthcare Corporation

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 16, 2008
Enrollment StartMar 1, 2008
Primary CompletionMay 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 18.2 years ago